Telix Pharmaceuticals | TLX - Net Income



Telix Pharmaceuticals reported AUD10.13M in Net Income for its fiscal semester ending in December of 2024.


Net Income Change Date
Cochlear AUD 205.1M 39.7M Dec/2024
CSL USD 2.01B 1.27B Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103681000 68.4M Jun/2024
Medical Developments International AUD 304K 15.32M Dec/2024
Mesoblast -55417000 22.88M Jun/2024
Neuren Pharmaceuticals AUD 134.03M 126.01M Dec/2024
Pacific Edge NZD -14503000 7.36M Sep/2024
Paradigm Biopharmaceuticals AUD -5924050 3.77M Dec/2024
Polynovo AUD 1.28M 1.41M Jun/2024
PYC Therapeutics AUD -25572620 14.25M Dec/2024
Ramsay Health Care AUD -104900000 235.1M Dec/2024
ResMed USD 379.7M 35.08M Jun/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024